|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
146,000,000 |
Market
Cap: |
19.31(B) |
Last
Volume: |
1,621,262 |
Avg
Vol: |
1,396,245 |
52
Week Range: |
$92.79 - $147.2 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 509 |
Guru Rank Value : 3.8 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co. provides whole-genome sequencing, genotyping, noninvasive prenatal testing (NIPT), and product support services. Using Co.'s services, customers can perform whole-genome sequencing projects and microarray projects (including large-scale genotyping studies and whole-genome association studies). Co. provides NIPT services through its partner laboratories that direct samples to Co. on a test send-out basis in its Clinical Laboratory Improvements Amendments-certified, College of Pathologists-accredited laboratory. Co. also provides support services to customers who have purchased its products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,330 |
7,330 |
Total Buy Value |
$0 |
$0 |
$991,672 |
$991,672 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
0 |
0 |
315 |
22,201 |
Total Sell Value |
$0 |
$0 |
$35,545 |
$4,541,175 |
Total People Sold |
0 |
0 |
1 |
3 |
Total Sell Transactions |
0 |
0 |
1 |
16 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Desouza Francis A |
President and CEO |
|
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,159 |
89,682 |
|
- |
|
Desouza Francis A |
President and CEO |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,318 |
82,523 |
|
- |
|
Stapley Marc |
EVP & Chief Administrative Ofc |
|
2017-02-15 |
4 |
D |
$163.29 |
$979,903 |
D/D |
(6,001) |
42,641 |
|
- |
|
Stapley Marc |
EVP & Chief Administrative Ofc |
|
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,219 |
48,642 |
|
- |
|
Stapley Marc |
EVP & Chief Administrative Ofc |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,438 |
44,423 |
|
- |
|
Ronaghi Mostafa |
Sr VP & CTO |
|
2017-02-15 |
4 |
D |
$163.29 |
$792,446 |
D/D |
(4,853) |
66,585 |
|
- |
|
Ronaghi Mostafa |
Sr VP & CTO |
|
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,516 |
71,438 |
|
- |
|
Ronaghi Mostafa |
Sr VP & CTO |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,032 |
67,922 |
|
- |
|
Flatley Jay T |
Director |
|
2017-02-15 |
4 |
D |
$163.29 |
$3,643,816 |
D/D |
(22,315) |
519,176 |
|
- |
|
Flatley Jay T |
Director |
|
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
14,255 |
541,491 |
|
- |
|
Flatley Jay T |
Director |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
28,510 |
527,236 |
|
- |
|
Dadswell Charles |
Sr VP & General Counsel |
|
2017-02-15 |
4 |
D |
$163.29 |
$765,993 |
D/D |
(4,691) |
13,524 |
|
- |
|
Dadswell Charles |
Sr VP & General Counsel |
|
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,516 |
18,215 |
|
- |
|
Dadswell Charles |
Sr VP & General Counsel |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,032 |
14,699 |
|
- |
|
Ostadan Omead |
EVP Ops, Products, Strategy |
|
2017-02-15 |
4 |
D |
$163.29 |
$974,841 |
D/D |
(5,970) |
31,258 |
|
- |
|
Ostadan Omead |
EVP Ops, Products, Strategy |
|
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,219 |
37,228 |
|
- |
|
Ostadan Omead |
EVP Ops, Products, Strategy |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,438 |
33,009 |
|
- |
|
Bouchard Michel |
Chief Accounting Officer |
|
2017-02-15 |
4 |
D |
$163.29 |
$241,669 |
D/D |
(1,480) |
25,125 |
|
- |
|
Bouchard Michel |
Chief Accounting Officer |
|
2017-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,313 |
26,605 |
|
- |
|
Bouchard Michel |
Chief Accounting Officer |
|
2017-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,625 |
25,292 |
|
- |
|
Ostadan Omead |
EVP Ops, Products, Strategy |
|
2017-02-13 |
4 |
AS |
$163.10 |
$354,416 |
D/D |
(2,173) |
24,571 |
|
- |
|
Bowman A Blaine |
Director |
|
2017-02-08 |
4 |
AS |
$162.66 |
$488,231 |
D/D |
(3,000) |
15,704 |
|
- |
|
Bowman A Blaine |
Director |
|
2017-02-08 |
4 |
OE |
$42.82 |
$210,560 |
D/D |
3,000 |
18,704 |
|
- |
|
Dadswell Charles |
Sr VP & General Counsel |
|
2017-02-06 |
4 |
AS |
$161.26 |
$92,241 |
D/D |
(572) |
7,592 |
|
- |
|
Ostadan Omead |
EVP Ops, Products, Strategy |
|
2017-02-02 |
4 |
AS |
$160.41 |
$177,093 |
D/D |
(1,104) |
26,586 |
|
- |
|
1655 Records found
|
|
Page 35 of 67 |
|
|